AXL Is a Potential Target for the Treatment of Intestinal Fibrosis

By
Justin.choi
-
0
39
This study demonstrated that inhibition of AXL signaling with the small molecule inhibitor BGB324 abrogated both matrix-stiffness and transforming growth factor beta–induced fibrogenesis in human colonic myofibroblasts.
[Inflammatory Bowel Diseases]
6606345 {6606345:ES3PR5GV} 1 apa 50 default 1 151880 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Abstract